To recover your password please fill in your email address
Please fill in below form to create an account with us
A phase 3 double-blind placebo-controlled randomized trial of methoxyflurane with periprostatic local anaesthesia (PILA) to reduce the discomfort of transrectal ultrasound-guided prostate biopsy (ANZUP1501).
See ANZCTR for full trial details >
|
Trial Summary: |
This study aims to determine whether the addition of inhaled methoxyflurane to PILA improves the pain, discomfort and experience of TRUS biopsy, thereby increasing men's willingness to undergo repeat TRUS prostate biopsy. |
|
Supported By: |
Cancer Australia; Prostate Cancer Foundation Australia (PCFA); Medical Developments International (MDI) |
|
Eligibility: |
The target population for this study is men (18 years and over) scheduled to undergo their first TRUS biopsy of the prostate for a raised PSA or abnormal digital rectal examination (DRE). |
|
Registration ID: |
ACTRN12615001105538 and NCT02604225 |
|
Participation: |
Australia and New Zealand |
|
Australian Lead Group: |
ANZUP |
|
Status: |
Completed |
|
Activation Date: |
First Site Activated 17-Dec-2015 |
|
Chairs: |
Mr Nicholas Buchan |
|
Contact: |